Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2013 | 05-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 1,300 | 0 | 1,471 | 1,919 | 1,682 |
| Operating Income | -1,300 | 0 | -1,471 | -1,919 | -1,682 |
| Interest Expense | 316 | 0 | 309 | 235 | 274 |
| Other Income | 1,805 | 0 | -1,990 | -3,179 | 0 |
| Pre-tax Income | 188 | 0 | -3,770 | -5,333 | -1,956 |
| Income Tax | 3 | 0 | N/A | 2 | N/A |
| Net Income Continuous | 186 | 0 | -3,770 | -5,335 | -1,956 |
| Net Income | $186 | $0 | $-3,770 | $-5,335 | $-1,956 |
| EPS Basic Total Ops | 0.30 | N/A | -5.71 | -25.53 | -3.60 |
| EPS Basic Continuous Ops | 0.27 | N/A | -5.92 | -8.76 | -3.44 |
| EPS Diluted Total Ops | -0.60 | N/A | -5.71 | -25.53 | -3.60 |
| EPS Diluted Continuous Ops | 0.26 | N/A | -5.92 | -8.76 | -3.44 |
| EBITDA(a) | $-1,194 | $0 | $-1,556 | $-1,628 | $-1,636 |